Lori Lieberman & Associates, Nutrition Consultants

  • About
    • Our Practice
    • Insurance Coverage
  • Team
  • Nutrition Therapy
    • Conditions
    • Resources
    • Blog
  • FAQ
  • Testimonials
  • Contacts
  • Search

Where do I stand on Ozempic, Wegovy, Mounjaro & other GLP1s? Not with #weightwatchers!

November 14, 2023 by Lori Lieberman Dieting, Obesity, Uncategorized, Weight Loss
Image credit: https://the-dots.com/projects/the-i-m-tired-project-185468 Yes, blaming individuals for living in larger bodies–the way Weight Watchers* and frankly most health care providers have done—may thankfully be changing. It’s a long overdue shift. The weight-centric healthcare model — in other words, ‘if you’re
Read More

Before prescribing Ozempic/Mounjaro/Wegovy

October 24, 2023 by Lori Lieberman Dieting, Weight Loss
A note to physicians. So your patients want to start Ozempic/Mounjaro/Wegovy? Please, please, please consider the following: Screening for an eating disorder Use SCOFF, designed for primary care providers: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1070794/ It takes 2 minutes It’s highly sensitive and specific Referring
Read More

Macros Really Don’t Matter — Not even carbs!

March 10, 2023 by Jessica Shaw Dieting, Eating Disorder Recovery
Atypical Anorexia Nervosa: What it is and how we can help A patient walks into the nutrition office feeling frustrated that her calorie restriction and countless hours of exercise have not been successful in sustained weight loss. She reports feeling
Read More

Thinking about starting Wegovy, Mounjaro or other meds for weight loss?

March 10, 2023 by Tori Stowell Dieting, News, Obesity
Think about these issues first. If you’ve spent any time on social media recently, you’ve probably caught wind of the latest trending topic in weight loss: use of Ozempic, Wegovy, Trulicity, and Saxenda. This class of prescription medications, GLP1RAs, is
Read More
Phone: 781-335-7559.
Email: info@LoriLiebermanAndAssociates.com
Privacy Policy.
© 2017 Lori Lieberman & Associates.
 

Loading Comments...